Company / Book Value per Share
Aurinia Pharmaceuticals Inc. Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$4.126
FY2025
5-year range
$2.624 / $4.126
FY2021-FY2025
Trend
+57.2%
vs FY2024
Sector context
#118 of 209
Health Care
What the data says
At $4.126, Aurinia Pharmaceuticals Inc.'s book value per share ranks #118 of 209 in the Health Care sector. Book Value per Share returned to growth in FY2025 after 2 years of decline, reaching $4.126.
Based on SEC 10-K filings.
$4.126 in FY2025 with a 5-year CAGR of -2.9%.
Improved from $2.669 to $4.126 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +8.6%
- 5-Year CAGR
- -2.9%
- 10-Year CAGR
- -
Sector benchmark
#118 of 209 in Health CareTop 56% of 209This company $4.126 Sector average $215.686
▼
-98.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -2.9%, indicating a declining trend.
- In FY2025, book value per share increased 57.2% year-over-year.
- Ranks #118 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.126 | +57.2% |
| FY2024 | $2.624 | -1.7% |
| FY2023 | $2.669 | -17.1% |
| FY2022 | $3.218 | +20.5% |
| FY2021 | $2.671 | -44.0% |
| FY2020 | $4.769 | +48.6% |
| FY2019 | $3.21 | +100.5% |
| FY2018 | $1.601 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026